Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Akebia quinata saponins** are triterpenoidal saponins isolated from the fruits and stems of *Akebia quinata*, a plant used in Traditional Chinese Medicine for antiphlogistic and urinary tract inflammatory conditions. These saponins, including **akebia saponin PA**, **hederacoside C**, and **hederacolchiside F**, exhibit bioactivities such as enhancing glucose-stimulated insulin secretion (GSIS) in pancreatic β-cells, with akebia saponin PA showing strong effects comparable to gliclazide in INS-1 cells via pathways involving PDX-1 overexpression, ERK1/2, IRS-2, PI3K, and Akt. They also demonstrate antinociceptive, anti-inflammatory properties, and antioxidant activity, attributed partly to hydrolysis into sapogenins like hederagenin and oleanolic acid.[1][2][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on akebia quinata saponins.